Autonomous Healthcare today announced that the U.S. Food and Drug Administration (FDA) has granted the De Novo marketing authorization for Syncron-E™, its software that supports respiratory therapists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results